Illumina’s Q4 revenue in 2024 was up 1% from the same period in 2023, totalling $1.1bn. Despite the positive end to the year, ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that ...

New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina ...

Illumina (ILMN) announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a software upgrade and new kits. The single-flow-cell NovaSeq X ...

In addition, the new NovaSeq X 25B 100 and 200-cycle kits are now available under Illumina's brand following the company's acquisition of Fluent. ILMN Stock’s Likely Trend Following the News ...

Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...

Illumina (ILMN) announced it is collaborating with Nvidia (NVDA) to advance technology platforms for the analysis and interpretation of ...

Illumina's latest offering was a brand-new ... the company calls "universal software"-meaning that the MiSeq i100 and NovaSeq X leverage many of the same software components, even though the ...

New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina, Inc.

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and investment participation. Finally turning attention to itself, the ...